Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Recruiting × Cabergoline × Clear all

Phase

Phase 4 1 Phase 3 1

Status

Completed 2 Recruiting 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prolactinoma 1 Prolactin Deficiency, Isolated 1 Hyperprolactinemia 1

Interventions

Propofol 8 Rituximab 7 Sevoflurane 6 Dexamethasone 6 Trastuzumab 5 Magnetic Resonance Spectroscopy 5 Enoxaparin 5 Carboplatin 5 Bevacizumab 5 Specimen Handling 4 Nivolumab 4 Indocyanine Green 4 Capecitabine 4 Bupivacaine 4 pembrolizumab 3 atezolizumab 3 apixaban 3 Lenalidomide 3 Gemcitabine 3 Docetaxel 3 Cyclophosphamide 3 zanubrutinib 2 venetoclax 2 trastuzumab deruxtecan 2 trametinib 2 tislelizumab 2 ribociclib 2 polyethylene glycol 3350 2 pirtobrutinib 2 pertuzumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07045935 2025-09-23

ProBOLIC

University Hospital, Basel, Switzerland

Phase 4 Recruiting

Prolactin Deficiency, Isolated, Hyperprolactinemia, Prolactinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡